Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking weight loss injections when you have gallstones is possible for many people, but it is not straightforward. GLP-1 medicines like Mounjaro and Wegovy slow gastric emptying, which affects how bile moves through the digestive system — and that matters when gallstones are already present. A prescriber needs to weigh the clinical picture before any treatment is approved. These are prescription-only medicines, so clinical assessment is always required, and your gallbladder history is a key part of that conversation. If you are wondering whether you can use weight loss injections if you have gallstones, the short answer is: possibly, but not without careful review.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Weight loss injections like Mounjaro (tirzepatide) and Wegovy (semaglutide) work partly by slowing the rate at which the stomach empties. That is useful for appetite control, but it has a downstream effect: bile (the digestive fluid produced by the liver and stored in the gallbladder) spends longer sitting still between meals. Bile that pools rather than flows is more likely to become concentrated, which can encourage cholesterol crystals to form. Over time those crystals can solidify into gallstones, or cause existing stones to shift.
This is not a theoretical concern. The NHS medicines page for tirzepatide lists gallbladder problems (including gallstones and cholecystitis (inflammation of the gallbladder)) among the known side effects of Mounjaro. The same category of side effect appears in the semaglutide information. Incidence in trials is relatively low, but the signal is well-established enough that prescribers are required to discuss it.
The relationship runs in both directions. Rapid weight loss itself, independent of any medicine, encourages gallstone formation because the liver secretes more cholesterol into bile during periods of significant calorie deficit. GLP-1 medicines accelerate weight loss, which means the gallstone risk from weight reduction can be amplified compared with losing weight more slowly.
This is the practical question most people with a gallstone history want answered. The honest clinical position is: it depends, and a prescriber is the right person to make that call. Existing gallstones are not listed as an absolute contraindication in the licensed prescribing information for Mounjaro or Wegovy, but they are a risk factor that shapes the clinical decision.
Relevant considerations include whether your gallstones are currently asymptomatic or have caused episodes of pain or obstruction, whether your gallbladder is intact, and what other conditions and medications are in the picture. Someone with a longstanding incidental gallstone who has never had symptoms is in a different position from someone who has recently had biliary colic. Both situations require disclosure at consultation.
Our clinical team at nume reviews each consultation individually — a GPhC-registered prescriber reads your answers and medical history, not a scoring algorithm. Gallbladder history is one of the questions on our health assessment, and any prescriber would want to know about it before approving treatment. If you are wondering specifically whether you can use weight loss injections with gallstones, we have looked at that question in detail on a dedicated page. For a broader look at how weight loss injections relate to gallstone risk, we have covered the evidence in more detail separately.
One thing you can do right now: check whether the pharmacy you are considering is registered with the GPhC at pharmacyregulation.org/registers. It takes under a minute and tells you immediately whether you are dealing with a legitimate, regulated dispensing pharmacy.
If you are taking a weight loss injection and you develop severe or persistent pain in the upper right abdomen, pain that radiates to the back, pain paired with fever, jaundice (yellowing of the skin or whites of the eyes), or vomiting you cannot manage at home, stop and seek medical attention the same day. These symptoms can point to a gallbladder attack, cholecystitis, bile duct obstruction, or (in a different presentation) pancreatitis.
The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known infrequent but serious side effect of GLP-1 medicines. The warning signs overlap with gallbladder pain: severe stomach pain, particularly pain that moves towards the back, with or without vomiting. That update reinforced guidance already in the product information, and you can report any suspected side effects through the MHRA Yellow Card scheme.
Patients should tell their prescribing team at once if abdominal symptoms change in character or severity during treatment. This is not about causing alarm, the majority of people on GLP-1 medicines do not develop gallbladder complications. But the minority who do need prompt assessment, and waiting to mention it at the next check-in is the wrong call. Our aftercare team is available seven days a week precisely for situations like this.
Applying through our free consultation gives a prescriber the information they need to make an individual clinical decision. You disclose your gallstone history, any previous treatment or surgery, and current symptoms. The prescriber may approve treatment with specific monitoring guidance, recommend deferring until your gallbladder situation is more stable, or advise against treatment if the risk-benefit balance does not support it for you specifically.
That decision is made the same day you apply. If treatment is approved and clinically suitable, your prescription is issued the same day, your pen is dispatched from our GPhC-registered pharmacy, and it arrives via DPD the next working day in plain, unbranded packaging. If you want to understand how weight loss injections and gallstones interact before you apply, that page brings together the key evidence and practical guidance in one place. If you want to understand the wider landscape of weight loss injections available in the UK before you apply, that page covers both licensed medicines in detail.
Worth knowing: people who have had their gallbladder removed face a different set of considerations, which we address separately. And if you are not yet sure whether you are likely to meet the eligibility criteria, the FAQs page covers the most common threshold questions.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.